Correction: Effective drug treatment identified by in vivo screening in a transplantable patient-derived xenograft model of chronic myelomonocytic leukemia
1 Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.
2 Department of Biomedical Engineering, Vanderbilt University, Nashville, TN, 37235, USA.
3 Institute of Experimental Hematology, Hannover Medical School, Hannover, Germany.
4 Pediatric Hematology and Oncology, Hannover Medical School, Hannover, Germany.
5 Department of Pediatric Hematology and Oncology, Martin-Luther-University Halle-Wittenberg, Halle, Germany.
6 Division of Hematology/Oncology, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.
7 Department of Pediatrics, University of Washington, Seattle, WA, USA.
8 Terry Fox Laboratory, British Columbia Cancer Agency, Vancouver, BC, Canada.
9 Department of Medicine, University of British Columbia, Vancouver, BC, Canada.
10 Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany. heuser.michael@mh-hannover.de.